Tesaro Announces Participation in Two Investor Conferences

WALTHAM, Mass., April 25, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences are:

• The Leerink Boston Biopharma Bus Tour on Wednesday, May 10, 2017. Lonnie Moulder, CEO, Mary Lynne Hedley, Ph.D., President and COO, and Tim Pearson, EVP and CFO of TESARO, will present at 1:00 PM ET and will answer questions from investors. 
• The Bank of America Merrill Lynch 2017 Healthcare Conference at the Loews Hotel in Las Vegas, Nevada on Wednesday, May 17, 2017. Tim Pearson will participate in an analyst-led moderated Q&A at 3:00 PM PT and in meetings with investors.

       A live webcast of the presentation at the Bank of America conference will be available by visiting the Investors section of the TESARO website at www.tesarobio.com. An archived replay of this webcast will be available on the Company’s website for 14 days following the conferences.

About TESAROTESARO is an oncology-focused biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer. For more information, visit www.tesarobio.com, and follow us on Twitter and LinkedIn.

For additional information, please contact:    
Jennifer Davis
1.781.325.1116
[email protected]

You May Also Be Interested In

• SpecialtyRx Fills Booth 713 at FHCA 2026 with 20x20 Island Exhibit
• VEVOR Monthly Power 15 Returns August 15-18, Powering the Back-to-Project Season
• HIVE Reports Q1 2027 Revenue of $79.1 Million; Contracted GPU Cloud ARR(1) Reaches Approximately $110 million